Latest Breaking News On - Nuvalent inc - Page 17 : comparemela.com

Nuvalent (NASDAQ: NUVL) up 35% on lung cancer trial results

Nuvalent (NASDAQ: NUVL) up 35% on lung cancer trial results
dhakatribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dhakatribune.com Daily Mail and Mail on Sunday newspapers.

United statesNuvalent inc

Nuvalent (NASDAQ:NUVL) Sees Unusually-High Trading Volume After Analyst Upgrade

Shares of Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) saw an uptick in trading volume on Thursday after BMO Capital Markets raised their price target on the stock from $52.00 to $73.00. BMO Capital Markets currently has an outperform rating on the stock. 325,004 shares were traded during mid-day trading, an increase of 1% from […]

Deborah ann millerLeerink partnrsStifel nicolausNuvalent incGoldman sachs group incNuveen asset managementSecurities exchange commissionWells fargo companyNuvalent company profileGet free reportDarlene nociExchange commissionAsset managementGoldman sachs groupSachs groupNuvalent daily

Preliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial of NVL-655 Demonstrated Activity in Heavily Pre-Treated Patients with ALK-Positive NSCLC and an ALK-Selective, TRK-Sparing Safety Profile

/PRNewswire/ Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically.

United statesUnited kingdomChristopher turnerJessicaj linNuvalent incCompany quarterly report on formPrnewswire nuvalent incExchange commissionChief medical officerPoster sessionMassachusetts general hospitalConference callPrivate securities litigation reform actQuarterly report

Nuvalent (NUVL) Says Prelim Phase 1 Data from ALKOVE-1 Trial of NVL-655 Demonstrated Activity in Pre-Treated Patients with ALK-Positive NSCLC and ALK-Selective, TRK-Sparing Safety Profile

Nuvalent (NUVL) Says Prelim Phase 1 Data from ALKOVE-1 Trial of NVL-655 Demonstrated Activity in Pre-Treated Patients with ALK-Positive NSCLC and ALK-Selective, TRK-Sparing Safety Profile
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesChristopher turnerJessicaj linNuvalent incChief medical officerPoster sessionMassachusetts general hospitalConference call

Nuvalent (NASDAQ:NUVL) Coverage Initiated at Stifel Nicolaus

Stifel Nicolaus began coverage on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a report published on Tuesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $65.00 price target on the stock. Several other brokerages also recently weighed in on NUVL. SVB Leerink began coverage on Nuvalent in a research report on […]

Christopher durant turnerStifel nicolausLeerink partnrsAllspring global investments holdingsNuvalent incAmeritas investment partners incLife insurance coRoyal bankFree reportMarketbeat ratingsModerate buyGet free reportDarlene nociInvestment partnersNuvalent dailyNasdaq nuvl